Abstract
The focuses of this work are: to propose a novel method for building an ensemble of classifiers for peptide classification based on substitution matrices; to show the importance to select a proper set of the parameters of the classifiers that build the ensemble of learning systems. The HIV-1 protease cleavage site prediction problem is here studied. The results obtained by a blind testing protocol are reported, the comparison with other state-of-the-art approaches, based on ensemble of classifiers, allows to quantify the performance improvement obtained by the systems proposed in this paper. The simulation based on experimentally determined protease cleavage data has demonstrated the success of these new ensemble algorithms. Particularly interesting it is to note that also if the HIV-1 protease cleavage site prediction problem is considered linearly separable we obtain the best performance using an ensemble of non-linear classifiers.
Keywords: Machine learning, ensembles of classifiers, substitution matrices, HIV-1 protease prediction
Protein & Peptide Letters
Title: A Further Step Toward an Optimal Ensemble of Classifiers for Peptide Classification, a Case Study: HIV Protease
Volume: 16 Issue: 2
Author(s): Loris Nanni and Alessandra Lumini
Affiliation:
Keywords: Machine learning, ensembles of classifiers, substitution matrices, HIV-1 protease prediction
Abstract: The focuses of this work are: to propose a novel method for building an ensemble of classifiers for peptide classification based on substitution matrices; to show the importance to select a proper set of the parameters of the classifiers that build the ensemble of learning systems. The HIV-1 protease cleavage site prediction problem is here studied. The results obtained by a blind testing protocol are reported, the comparison with other state-of-the-art approaches, based on ensemble of classifiers, allows to quantify the performance improvement obtained by the systems proposed in this paper. The simulation based on experimentally determined protease cleavage data has demonstrated the success of these new ensemble algorithms. Particularly interesting it is to note that also if the HIV-1 protease cleavage site prediction problem is considered linearly separable we obtain the best performance using an ensemble of non-linear classifiers.
Export Options
About this article
Cite this article as:
Nanni Loris and Lumini Alessandra, A Further Step Toward an Optimal Ensemble of Classifiers for Peptide Classification, a Case Study: HIV Protease, Protein & Peptide Letters 2009; 16 (2) . https://dx.doi.org/10.2174/092986609787316199
DOI https://dx.doi.org/10.2174/092986609787316199 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
Call for Papers in Thematic Issues
Therapeutic Proteins and Peptides of Plant Origin
Plants are still the major repository of biologically active substances. In the last two decades, however, natural peptides and proteins of plant origin have gained increasing attention due to their pharmacological activities over a variety of human illnesses, including those mediated by infections and parasitosis and those involving different cellular ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The mRNA Technology in Cancer Immunotherapy
Current Nanomaterials Targeting DNA Topoisomerase I with Non-Camptothecin Poisons
Current Medicinal Chemistry Syntheses and N-methyl-D-aspartate Receptor Antagonist Pharmacology of Fluorinated Arylcycloheptylamines
Medicinal Chemistry Diazenyl Derivatives as Therapeutic and Diagnostic Agents Acting on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Mortality Predictors of Pre-variant SARS-CoV-2 Infected ARDS Patients Receiving Favipiravir and Tocilizumab
Current Respiratory Medicine Reviews Refined Purification of Large Amounts of Rat cvHsp/HspB7 and Partial Biological Characterization In Vitro
Protein & Peptide Letters Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas
Letters in Drug Design & Discovery Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges
Coronaviruses CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View
Current Topics in Medicinal Chemistry Natural Products as a Paradigm for the Treatment of Coxsackievirus - induced Myocarditis
Current Topics in Medicinal Chemistry Quercetin Ameliorates Neuropathic Pain after Brachial Plexus Avulsion <i>via</i> Suppressing Oxidative Damage through Inhibition of PKC/MAPK/ NOX Pathway
Current Neuropharmacology Withdrawal Notice: Current scenario of COVID-19
Letters in Drug Design & Discovery Biosensor Detection of COVID-19 in Lung Cancer: Hedgehog and Mucin Signaling Insights
Current Pharmaceutical Design Sulfated Oligosaccharides: New Targets for Drug Development?
Current Medicinal Chemistry Ezetimibe and other Azetidinone Cholesterol Absorption Inhibitors
Current Topics in Medicinal Chemistry Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Synthesis, Antimicrobial Evaluation and Docking Study of Novel 3,5-Disubstituted-2-Isoxazoline and 1,3,5-Trisubstituted-2-Pyrazoline Derivatives
Medicinal Chemistry Improvement in Material Properties of Thermal Energy Storage Medium with Nanostructured Materials
Nanoscience & Nanotechnology-Asia The Association between COVID-19 and Reactive Arthritis: A Systematic Review of Case Reports and Case Series
Current Rheumatology Reviews Imatinib and Its Successors – How Modern Chemistry has Changed Drug Development
Current Pharmaceutical Design